8-K
filed February 28, 2023, 6:59 PM ET
ticker SUPN
CIK 0001356576
earnings
confidence high
sentiment positive
materiality 0.80
Supernus Q4/FY2022: total rev $667.2M (+15% YoY); Qelbree sales $61.3M; FY2023 rev guidance $580-620M
SUPERNUS PHARMACEUTICALS, INC.
2022-FY EPS reported
$1.04
revenue$667,238,000
- Full year 2022 total revenues $667.2M (+15% YoY); Q4 net product sales $163.8M (+6% vs Q4 2021).
- Qelbree net sales $61.3M in FY2022 (vs $9.9M in FY2021); GOCOVRI $104.4M (+19% vs FY2021).
- GAAP diluted EPS $1.04 for FY2022 (Q4: $0.43); non-GAAP operating earnings $148.8M.
- FY2023 revenue guidance $580-620M (excl. Trokendi XR), ~30% growth; non-GAAP op earnings $65-95M.
- Cash $555.2M at Dec 2022; $150M credit line from UBS; SPN-830 FDA meeting April 2023; SPN-820 Phase II ongoing.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SUPERNUS PHARMACEUTICALS, INC. reported the full year ended December 31, 2022 results: revenue $667.2 million. Guidance initiated.
- Period
- the full year ended December 31, 2022
- Revenue
- $667.2 million
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Full Year 2022 total revenues of $667.2 million, a 15% increase compared to full year 2021
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SUPERNUS PHARMACEUTICALS, INC. updated its the fourth quarter ended December 31, 2022 guidance (initiated).
- Period
- the fourth quarter ended December 31, 2022
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
On February 28, 2023, Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) issued a press release regarding its financial results for the fourth quarter and full year ended December 31, 2022.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.